An allosteric modulator of RNA binding targeting the N-terminal domain of TDP-43 yields neuroprotective properties

N Mollasalehi, L Francois-Moutal, DD Scott… - ACS chemical …, 2020 - ACS Publications
N Mollasalehi, L Francois-Moutal, DD Scott, JA Tello, H Williams, B Mahoney, JM Carlson…
ACS chemical biology, 2020ACS Publications
In this study, we targeted the N-terminal domain (NTD) of transactive response (TAR) DNA
binding protein (TDP-43), which is implicated in several neurodegenerative diseases. In
silico docking of 50K compounds to the NTD domain of TDP-43 identified a small molecule
(nTRD22) that is bound to the N-terminal domain. Interestingly, nTRD22 caused allosteric
modulation of the RNA binding domain (RRM) of TDP-43, resulting in decreased binding to
RNA in vitro. Moreover, incubation of primary motor neurons with nTRD22 induced a …
In this study, we targeted the N-terminal domain (NTD) of transactive response (TAR) DNA binding protein (TDP-43), which is implicated in several neurodegenerative diseases. In silico docking of 50K compounds to the NTD domain of TDP-43 identified a small molecule (nTRD22) that is bound to the N-terminal domain. Interestingly, nTRD22 caused allosteric modulation of the RNA binding domain (RRM) of TDP-43, resulting in decreased binding to RNA in vitro. Moreover, incubation of primary motor neurons with nTRD22 induced a reduction of TDP-43 protein levels, similar to TDP-43 RNA binding-deficient mutants and supporting a disruption of TDP-43 binding to RNA. Finally, nTRD22 mitigated motor impairment in a Drosophila model of amyotrophic lateral sclerosis. Our findings provide an exciting way of allosteric modulation of the RNA-binding region of TDP-43 through the N-terminal domain.
ACS Publications